Journal of Biochemistry Advance Access originally published online on January 24, 2008
Journal of Biochemistry 2008 143(6):725-729; doi:10.1093/jb/mvn011
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2008 The Japanese Biochemical Society
JB Minireview-New Paradigm in Glycobiology |
Biological Function of Fucosylation in Cancer Biology
Department of Molecular Biochemistry & Clinical Investigation, Osaka University Graduate School of Medicine, 1-7, Yamada-oka, Suita, 565-0871, Japan
*To whom correspondence should be addressed. Tel: +81 6 6879 2590, Fax: +81 6 6879 2590, E-mail: emiyoshi{at}sahs.med.osaka-u.ac.jp
Received November 15, 2007; Accepted November 22, 2007
| Abstract |
|---|
Fucosylation is one of the most common modifications involving oligosaccharides on glycoproteins or glycolipids. Fucosylation comprises the attachment of a fucose residue to N-glycans, O-glycans and glycolipids. O-Fucosylation, which is a special type of fucosylation, is very important for Notch signalling. The regulatory mechanisms for fucosylation are complicated. Many kinds of fucosyltransferases, the GDP-fucose synthesis pathway and GDP-fucose transporter are involved in the regulation of fucosylation. Increased levels of fucosylation have been reported in a number of pathological conditions, including inflammation and cancer. Therefore, certain types of fucosylated glycoproteins such as AFP-L3 or several kinds of antibodies, which recognize fucosylated oligosaccharides such as sialyl Lewis a/x, have been used as tumour markers. Furthermore, fucosylation of glycoproteins regulates the biological functions of adhesion molecules and growth factor receptors. Changes in fucosylation could provide a novel strategy for cancer therapy. In this review, the biological significance of and regulatory pathway for fucosylation have been described.
Key Words: fucosylation, HCC, AFP-L3, fucosyltransferase, GDP-fucose
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. M. Drake, W. Cho, B. Li, A. Prakobphol, E. Johansen, N. L. Anderson, F. E. Regnier, B. W. Gibson, and S. J. Fisher Sweetening the Pot: Adding Glycosylation to the Biomarker Discovery Equation Clin. Chem., February 1, 2010; 56(2): 223 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gornik, J. Wagner, M. Pucic, A. Knezevic, I. Redzic, and G. Lauc Stability of N-glycan profiles in human plasma Glycobiology, December 1, 2009; 19(12): 1547 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J Krambeck, S. V Bennun, S. Narang, S. Choi, K. J Yarema, and M. J Betenbaugh A mathematical model to derive N-glycan structures and cellular enzyme activities from mass spectrometric data Glycobiology, November 1, 2009; 19(11): 1163 - 1175. [Abstract] [Full Text] [PDF] |
||||

